ClinicalTrials.gov
public full text
Public Domain
Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects
The purpose of this research study is to understand whether there is any difference in the amount of tasimelteon in the blood in smokers versus non-smokers. Additionally, this study will provide an assessment of the effect, if any, of age and body size on the safety and tolerability profile and the pharmacokinetics of tasimelteon.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity#353386
- Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age#805958
- A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes#893278
- Impact of Isotretinoin in Different Doses on Quality of Life#1086215
- This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects#903118
Record · ID 864252
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive